Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GenoDeep logo — Cancer Screening Using AI

GenoDeep

Cancer Screening Using AI

Founded 2018 Iran Iran 2-10 employees AI, Biotechnology +2

General Information

Company Name GenoDeep
Founded Year 2018
Location Iran Iran +1
Employees 2-10
Industries AI, Biotechnology, Health Care +1
Social

Get notified when GenoDeep moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GenoDeep

GenoDeep is a pioneering AI startup revolutionizing cancer screening with its innovative deep learning algorithms. Using just an ordinary blood sample, GenoDeep can detect malignancy in eight types of cancers, including Ovary, Liver, Stomach, Pancreas, Esophagus, Colorectum, Lung, and Breast, at early stages. By analyzing altered cfDNAs and protein biomarkers from blood through its proprietary technology, GenoDeep aims to provide accurate and localized detection, significantly improving prognosis and treatment outcomes. Founded in 2018, GenoDeep operates at the intersection of Biotechnology, Health Care, and Machine Learning. The company's groundbreaking approach has garnered attention from venture capital firms and investors, positioning it as a game-changer in the realm of cancer diagnostics. As of now, specific details about its last investment and investors have not been publicly disclosed. In summary, GenoDeep's mission to transform cancer screening using AI-driven technology holds immense promise in reshaping the future of healthcare. As the company continues to advance its groundbreaking solution, it remains an intriguing prospect for investors seeking impactful opportunities within the rapidly evolving biotech and AI sectors.

Taxonomy: AI-based Cancer Screening, Deep Learning Algorithms, Early Cancer Detection, Genomic and Protein Data Analysis, Medical Diagnostics, Healthcare Innovation, Precision Medicine, Biomedical Technology

No funding data available for GenoDeep yet.

Get notified when GenoDeep raises funding

GenoDeep Alternatives & Competitors

GenoDeep vs
Leukaemia Foundation
Leukaemia Foundation Australia

The Leukaemia Foundation stands with Australia to help cure and conquer every blood cancer – with ca...

219 employees
Health Care
GenoDeep vs
CBMC Cancer Center
CBMC Cancer Center

Comprehensive treatments for a wide spectrum of blood disorders and cancers.

Health Care
GenoDeep vs
Cure Leukaemia
Cure Leukaemia United Kingdom

We fund the Trials Acceleration Programme (TAP) which delivers & connects patients to blood cancer c...

23 employees
Health Care

FAQ About GenoDeep

Cancer Screening Using AI
GenoDeep was founded in 2018.
GenoDeep is headquartered in Iran.
GenoDeep operates in the following industries: AI, Biotechnology, Health Care, Machine Learning.
GenoDeep has approximately 2-10 employees.
Top alternatives and competitors to GenoDeep include Leukaemia Foundation, CBMC Cancer Center, Cure Leukaemia, Cellsway, Rocky Mountain Cancer Centers. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenoDeep and Leukaemia Foundation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GenoDeep and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy